These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

808 related items for PubMed ID: 17463069

  • 1. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
    Hamamcioglu K, Reder AT.
    Mult Scler; 2007 May; 13(4):459-70. PubMed ID: 17463069
    [Abstract] [Full Text] [Related]

  • 2. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
    Ochi H, Feng-Jun M, Osoegawa M, Minohara M, Murai H, Taniwaki T, Kira J.
    J Neurol Sci; 2004 Jul 15; 222(1-2):65-73. PubMed ID: 15240198
    [Abstract] [Full Text] [Related]

  • 3. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M, Schreiner B, Kieseier BC, Neuhaus O, Dichgans J, Hartung HP, Weller M, Wiendl H.
    J Neuroimmunol; 2005 Feb 15; 159(1-2):155-64. PubMed ID: 15652415
    [Abstract] [Full Text] [Related]

  • 4. Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression.
    Krakauer M, Sorensen P, Khademi M, Olsson T, Sellebjerg F.
    Mult Scler; 2008 Jun 15; 14(5):622-30. PubMed ID: 18424480
    [Abstract] [Full Text] [Related]

  • 5. Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-beta 1a, and high doses of immunoglobulins.
    Sarchielli P, Zaffaroni M, Floridi A, Greco L, Candeliere A, Mattioni A, Tenaglia S, Di Filippo M, Calabresi P.
    Mult Scler; 2007 Apr 15; 13(3):313-31. PubMed ID: 17439900
    [Abstract] [Full Text] [Related]

  • 6. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B, Mitsdoerffer M, Kieseier BC, Chen L, Hartung HP, Weller M, Wiendl H.
    J Neuroimmunol; 2004 Oct 15; 155(1-2):172-82. PubMed ID: 15342209
    [Abstract] [Full Text] [Related]

  • 7. Long-term favorable response to interferon beta-1b is linked to cytokine deviation toward the Th2 and Tc2 sides in Japanese patients with multiple sclerosis.
    Mei FJ, Osoegawa M, Ochi H, Minohara M, Nan S, Murai H, Ishizu T, Taniwaki T, Kira J.
    J Neurol Sci; 2006 Jul 15; 246(1-2):71-7. PubMed ID: 16581087
    [Abstract] [Full Text] [Related]

  • 8. IFN-beta1a and IFN-beta1b have different patterns of influence on cytokines.
    Sega S, Wraber B, Mesec A, Horvat A, Ihan A.
    Clin Neurol Neurosurg; 2004 Jun 15; 106(3):255-8. PubMed ID: 15177779
    [Abstract] [Full Text] [Related]

  • 9. B cells as a therapeutic target for IFN-β in relapsing-remitting multiple sclerosis.
    Ramgolam VS, Sha Y, Marcus KL, Choudhary N, Troiani L, Chopra M, Markovic-Plese S.
    J Immunol; 2011 Apr 01; 186(7):4518-26. PubMed ID: 21368231
    [Abstract] [Full Text] [Related]

  • 10. Interferon-beta therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanism.
    Azoulay D, Mausner-Fainberg K, Urshansky N, Fahoum F, Karni A.
    J Neuroimmunol; 2009 Jun 25; 211(1-2):114-9. PubMed ID: 19419774
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of interferon-β1b on cytokine patterns of CD4+ and CD8+ T cells derived from RRMS and PPMS patients.
    Skrzipek S, Vogelgesang A, Bröker BM, Dressel A.
    Mult Scler; 2012 May 25; 18(5):674-8. PubMed ID: 22025329
    [Abstract] [Full Text] [Related]

  • 12. IFN-beta inhibits the ability of T lymphocytes to induce TNF-alpha and IL-1beta production in monocytes upon direct cell-cell contact.
    Jungo F, Dayer JM, Modoux C, Hyka N, Burger D.
    Cytokine; 2001 Jun 07; 14(5):272-82. PubMed ID: 11444907
    [Abstract] [Full Text] [Related]

  • 13. Dysregulated neurotrophin mRNA production by immune cells of patients with relapsing remitting multiple sclerosis.
    Urshansky N, Mausner-Fainberg K, Auriel E, Regev K, Farhum F, Karni A.
    J Neurol Sci; 2010 Aug 15; 295(1-2):31-7. PubMed ID: 20541775
    [Abstract] [Full Text] [Related]

  • 14. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
    Bongioanni P, Romano MR, Boccardi B, Lombardo F, Moscato G, Mosti S, Baldini C, Nuti S, Meucci G, Rossi B.
    Rev Neurol; 2010 Aug 15; 29(10):893-9. PubMed ID: 10637835
    [Abstract] [Full Text] [Related]

  • 15. Interferon-beta induces brain-derived neurotrophic factor in peripheral blood mononuclear cells of multiple sclerosis patients.
    Lalive PH, Kantengwa S, Benkhoucha M, Juillard C, Chofflon M.
    J Neuroimmunol; 2008 Jul 15; 197(2):147-51. PubMed ID: 18555540
    [Abstract] [Full Text] [Related]

  • 16. Defective production of anti-inflammatory cytokine, TGF-beta by T cell lines of patients with active multiple sclerosis.
    Mokhtarian F, Shi Y, Shirazian D, Morgante L, Miller A, Grob D.
    J Immunol; 1994 Jun 15; 152(12):6003-10. PubMed ID: 8207225
    [Abstract] [Full Text] [Related]

  • 17. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
    Kebir H, Ifergan I, Alvarez JI, Bernard M, Poirier J, Arbour N, Duquette P, Prat A.
    Ann Neurol; 2009 Sep 15; 66(3):390-402. PubMed ID: 19810097
    [Abstract] [Full Text] [Related]

  • 18. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
    Marckmann S, Wiesemann E, Hilse R, Trebst C, Stangel M, Windhagen A.
    Clin Exp Immunol; 2004 Dec 15; 138(3):499-506. PubMed ID: 15544628
    [Abstract] [Full Text] [Related]

  • 19. T cell lymphokine-induced secretion of cytokines by monocytes from patients with multiple sclerosis.
    Maimone D, Reder AT, Gregory S.
    Cell Immunol; 1993 Jan 15; 146(1):96-106. PubMed ID: 8425234
    [Abstract] [Full Text] [Related]

  • 20. Synergistic immunomodulatory effects of interferon-beta1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing-remitting multiple sclerosis.
    Weber F, Polak T, Günther A, Kubuschok B, Janovskaja J, Bitsch A, Poser S, Rieckmann P.
    Ann Neurol; 1998 Jul 15; 44(1):27-34. PubMed ID: 9667590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.